FDA Inspection 765724 — Biogenesis, Inc

Biogenesis, Inc — FEI 3004933570

The FDA completed an inspection of Biogenesis, Inc on Feb 2, 2012 in Paterson, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 2, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Paterson, NJ (United States)

Citations

IDCFRDescription
180321 CFR 211.84(b)Representative Samples Criteria
202621 CFR 211.192Quality control unit review of records
435221 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.